- Target Species
- Species Cross-Reactivity
|Target Species||Cross Reactivity|
- N.B. Antibody reactivity and working conditions may vary between species.
- Product Form
- Purified IgG - liquid
- Purified IgG prepared by affinity chromatography on Protein A from tissue culture supernatant
- Buffer Solution
- Phosphate buffered saline
- Preservative Stabilisers
- 0.09% Sodium Azide (NaN3)
- Approx. Protein Concentrations
- IgG concentration 1.0 mg/ml
- Store at +4oC or at -20oC if preferred.
Storage in frost-free freezers is not recommended.
This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
- 12 months from date of despatch
- Entrez Gene
- GO Terms
regulation of the force of heart contraction
positive regulation of mesenchymal cell proliferation
negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis
response to virus
interferon-gamma receptor binding
response to drug
negative regulation of gene-specific transcription from RNA polymerase II promoter
positive regulation of synaptic transmission, cholinergic
positive regulation of peptidyl-serine phosphorylation of STAT protein
positive regulation of tyrosine phosphorylation of Stat1 protein
positive regulation of neuron differentiation
positive regulation of cell adhesion
negative regulation of metanephric nephron tubule epithelial cell differentiation
- For research purposes only
This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.
Applications of IFN Gamma antibody
|Immunohistology - Frozen
Where this antibody has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the antibody for use in their own system using appropriate negative/positive controls.
Copyright © 2021 Bio-Rad Antibodies (formerly AbD Serotec)
Secondary Antibodies Available
Negative Isotype Controls Available
Application Based External Images
Product Specific References
van der Meide PH et al. (1989) Isolation and characterization of monoclonal antibodies directed to rat interferon-gamma.
Lymphokine Res. 8 (4): 439-49.
References for IFN Gamma antibody
Paineau, J. et al. (1991) Effect of recombinant interferon gamma and interleukin-2 and of a monoclonal antibody against interferon gamma on the rat immune response against heart allografts.
J Heart Lung Transplant. 10 (3): 424-30.
Paineau, J. et al.. (1989) Effects of gamma interferon and interleukin-2, and of gamma-interferon antibodies, on the rat immune response against allografts.
Transplant Proc. 21: 999-1001.
van der Meide, P.H. et al. (1986) The purification and characterization of rat gamma interferon by use of two monoclonal antibodies.
J Gen Virol. 67 ( Pt 6): 1059-71.
Keller, R. et al. (1987) Induction, maintenance, and reinduction of tumoricidal activity in bone marrow-derived mononuclear phagocytes by Corynebacterium parvum. Evidence for the involvement of a T cell- and interferon-gamma-independent pathway of macrophage activation.
J Immunol. 138 (7): 2366-71.
Jacob, C.O. et al. (1989) Heterogeneous effects of IFN-gamma in adjuvant arthritis.
J Immunol. 142 (5): 1500-5.
Kingston, A.E. et al. (1989) Schwann cells co-cultured with stimulated T cells and antigen express major histocompatibility complex (MHC) class II determinants without interferon-gamma pretreatment: synergistic effects of interferon-gamma and tumor necrosis factor on MHC class II induction.
Eur J Immunol. 19 (1): 177-83.
Graf, M.R. et al. (2001) IL-6 secretion by a rat T9 glioma clone induces a neutrophil-dependent antitumor response with resultant cellular, antiglioma immunity.
J Immunol. 166 (1): 121-9.
Elflein, K. et al. (2003) Rapid recovery from T lymphopenia by CD28 superagonist therapy.
Blood. 102: 1764-70.
Straube, F. and Herrmann, T. (2001) Differential modulation of CD8beta by rat gammadelta and alphabeta T cells after activation.
Immunology. 104: 252-8.
How to Use the Spectraviewer?
Start by selecting the application you are interested in, with the option to select an instrument from the drop down menu or create a customized instrument
Select the fluorophores or fluorescent proteins you want to include in your panel to check compatibility
Select the lasers and filters you wish to include
Select combined or multi-laser view to visualize the spectra